Department of Orthopaedics, Xijing Hospital, The Air Force Medical University, Xi'an, 710032, Shaanxi, People's Republic of China.
Department of Pharmaceutical Technology, Faculty of Pharmacy of the University of Coimbra, University of Coimbra, Coimbra, Portugal.
J Nanobiotechnology. 2022 Dec 10;20(1):522. doi: 10.1186/s12951-022-01735-9.
Critical-sized bone defects are always difficult to treat, and they are associated with a significant burden of disease in clinical practice. In recent decades, due to the fast development of biomaterials and tissue engineering, many bioinspired materials have been developed to treat large bone defects. Due to the excellent osteoblastic ability of black phosphorous (BP), many BP-based biomaterials have been developed to treat bone defects. Therefore, there are abundant studies as well as a tremendous amount of research data. It is urgent to conduct evidence-based research to translate these research data and results into validated scientific evidence. Therefore, in our present study, a qualitative systematic review and a quantitative meta-analysis were performed. Eighteen studies were included in a systematic review, while twelve studies were included in the meta-analysis. Our results showed that the overall quality of experimental methods and reports of biomaterials studies was still low, which needs to be improved in future studies. Besides, we also proved the excellent osteoblastic ability of BP-based biomaterials. But we did not find a significant effect of near-infrared (NIR) laser in BP-based biomaterials for treating bone defects. However, the quality of the evidence presented by included studies was very low. Therefore, to accelerate the clinical translation of BP-based biomaterials, it is urgent to improve the quality of the study method and reporting in future animal studies. More evidence-based studies should be conducted to enhance the quality and clinical translation of BP-based biomaterials.
临界尺寸的骨缺损一直难以治疗,并且在临床实践中与重大疾病负担相关。近几十年来,由于生物材料和组织工程的快速发展,已经开发出许多仿生材料来治疗大的骨缺损。由于黑磷(BP)具有出色的成骨能力,因此已经开发出许多基于 BP 的生物材料来治疗骨缺损。因此,有大量的研究和大量的研究数据。急需进行循证研究,将这些研究数据和结果转化为经过验证的科学证据。因此,在我们目前的研究中,进行了定性系统评价和定量荟萃分析。系统评价纳入了 18 项研究,荟萃分析纳入了 12 项研究。我们的结果表明,生物材料研究的实验方法和报告的整体质量仍然较低,未来的研究需要改进。此外,我们还证明了基于 BP 的生物材料具有出色的成骨能力。但是,我们没有发现近红外(NIR)激光在基于 BP 的生物材料治疗骨缺损中的显著作用。然而,纳入研究提供的证据质量非常低。因此,为了加速基于 BP 的生物材料的临床转化,迫切需要在未来的动物研究中提高研究方法和报告的质量。应进行更多基于证据的研究,以提高基于 BP 的生物材料的质量和临床转化。